|
|
Vaccine Detail
|
HSPPC-96 |
| Vaccine Information |
- Vaccine Name: HSPPC-96
- Target Pathogen: Cancer
- Target Disease: Cancer
- Vaccine Ontology ID: VO_0007616
- Type: Peptide
- Status: Research
- Immunization Route: Intramuscular injection (i.m.)
- Description: Autologous tumor-derived heat shock protein-peptide complex 96 (HSPPC-96) (Eton et al., 2010).
|
| Host Response |
|
Human Response
- Vaccine Immune Response Type: VO_0003057
- Immune Response: IFNgamma-producing cell count rose modestly in 5 of 26 patients and returned to baseline by week 8, with no discernible association with HSPPC-96 dosing or clinical parameters (Eton et al., 2010).
|
| References |
Eton et al., 2010: Eton O, Ross MI, East MJ, Mansfield PF, Papadopoulos N, Ellerhorst JA, Bedikian AY, Lee JE. Autologous tumor-derived heat-shock protein peptide complex-96 (HSPPC-96) in patients with metastatic melanoma. Journal of translational medicine. 2010; 8; 9. [PubMed: 20109236].
|
|
